plenti hreluc pgk hygro (Addgene inc)
Structured Review

Plenti Hreluc Pgk Hygro, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plenti+hreluc+pgk+hygro/pLenti+HRE-Luc+pGK+Hygro+(Plasmid+%23118706)/pm39823061-164-24-28
Average 92 stars, based on 5 article reviews
Images
1) Product Images from "Design and validation of cell-based potency assays for frataxin supplementation treatments."
Article Title: Design and validation of cell-based potency assays for frataxin supplementation treatments.
Journal: Molecular therapy. Methods & clinical development
doi: 10.1016/j.omtm.2024.101347
Figure Legend Snippet: Figure 3. Stable expression of exogenous human FXN in MUT MEFs (A) A schematic of the lentivirus vector pLenti hygro FXN encoding a human miniFXN gene. The miniFXN gene used in experiments contains fragments of the endogenous FXN 50UTR, promoter and intron 1, and all five exons of the gene. (B) Representative western blot demonstrating expression of exogenous FXN. The miniFXN encodes a C-terminal HA tag that results in a slightly greater molecular weight, as detected by western blot. (C) Quantitation of endogenous Fxn (*) and exogenous FXN by western blot. Gapdh was used as a normalization control. MUT+FXN designates cells expressing exogenous, human FXN. The experiment was performed three independent times. Results are plotted as mean values with standard deviations; (**p < 0.001, ***p < 0.0001).
Techniques Used: Expressing, Plasmid Preparation, Western Blot, Molecular Weight, Quantitation Assay, Control
Related Articles
Cloning:Article Title: Design and validation of cell-based potency assays for frataxin supplementation treatments Article Snippet: MEFs were seeded at 5 103–5 104 cells per well in 96-well plates and cultured for 48 h. ATP levels were measured using the Luminescent ATP Detection Assay Kit (Abcam, #ab113849) following the manufacturer’s recommendations. .. Cloning and packaging of pLenti hygro FXN-L A miniFXN construct expressing human FXN under the control of endogenous regulatory elements was cloned into the Article Title: Design and validation of cell-based potency assays for frataxin supplementation treatments. Article Snippet: MEFs were seeded at 5 103–5 104 cells per well in 96-well plates and cultured for 48 h. ATP levels were measured using the Luminescent ATP Detection Assay Kit (Abcam, #ab113849) following the manufacturer’s recommendations. .. Cloning and packaging of pLenti hygro FXN-L A miniFXN construct expressing human FXN under the control of endogenous regulatory elements was cloned into the Construct:Article Title: Design and validation of cell-based potency assays for frataxin supplementation treatments Article Snippet: MEFs were seeded at 5 103–5 104 cells per well in 96-well plates and cultured for 48 h. ATP levels were measured using the Luminescent ATP Detection Assay Kit (Abcam, #ab113849) following the manufacturer’s recommendations. .. Cloning and packaging of pLenti hygro FXN-L A miniFXN construct expressing human FXN under the control of endogenous regulatory elements was cloned into the Article Title: Design and validation of cell-based potency assays for frataxin supplementation treatments. Article Snippet: MEFs were seeded at 5 103–5 104 cells per well in 96-well plates and cultured for 48 h. ATP levels were measured using the Luminescent ATP Detection Assay Kit (Abcam, #ab113849) following the manufacturer’s recommendations. .. Cloning and packaging of pLenti hygro FXN-L A miniFXN construct expressing human FXN under the control of endogenous regulatory elements was cloned into the Expressing:Article Title: Design and validation of cell-based potency assays for frataxin supplementation treatments Article Snippet: MEFs were seeded at 5 103–5 104 cells per well in 96-well plates and cultured for 48 h. ATP levels were measured using the Luminescent ATP Detection Assay Kit (Abcam, #ab113849) following the manufacturer’s recommendations. .. Cloning and packaging of pLenti hygro FXN-L A miniFXN construct expressing human FXN under the control of endogenous regulatory elements was cloned into the Article Title: Design and validation of cell-based potency assays for frataxin supplementation treatments. Article Snippet: MEFs were seeded at 5 103–5 104 cells per well in 96-well plates and cultured for 48 h. ATP levels were measured using the Luminescent ATP Detection Assay Kit (Abcam, #ab113849) following the manufacturer’s recommendations. .. Cloning and packaging of pLenti hygro FXN-L A miniFXN construct expressing human FXN under the control of endogenous regulatory elements was cloned into the Control:Article Title: Design and validation of cell-based potency assays for frataxin supplementation treatments Article Snippet: MEFs were seeded at 5 103–5 104 cells per well in 96-well plates and cultured for 48 h. ATP levels were measured using the Luminescent ATP Detection Assay Kit (Abcam, #ab113849) following the manufacturer’s recommendations. .. Cloning and packaging of pLenti hygro FXN-L A miniFXN construct expressing human FXN under the control of endogenous regulatory elements was cloned into the Article Title: Design and validation of cell-based potency assays for frataxin supplementation treatments. Article Snippet: MEFs were seeded at 5 103–5 104 cells per well in 96-well plates and cultured for 48 h. ATP levels were measured using the Luminescent ATP Detection Assay Kit (Abcam, #ab113849) following the manufacturer’s recommendations. .. Cloning and packaging of pLenti hygro FXN-L A miniFXN construct expressing human FXN under the control of endogenous regulatory elements was cloned into the Clone Assay:Article Title: Design and validation of cell-based potency assays for frataxin supplementation treatments Article Snippet: MEFs were seeded at 5 103–5 104 cells per well in 96-well plates and cultured for 48 h. ATP levels were measured using the Luminescent ATP Detection Assay Kit (Abcam, #ab113849) following the manufacturer’s recommendations. .. Cloning and packaging of pLenti hygro FXN-L A miniFXN construct expressing human FXN under the control of endogenous regulatory elements was cloned into the Article Title: Design and validation of cell-based potency assays for frataxin supplementation treatments. Article Snippet: MEFs were seeded at 5 103–5 104 cells per well in 96-well plates and cultured for 48 h. ATP levels were measured using the Luminescent ATP Detection Assay Kit (Abcam, #ab113849) following the manufacturer’s recommendations. .. Cloning and packaging of pLenti hygro FXN-L A miniFXN construct expressing human FXN under the control of endogenous regulatory elements was cloned into the Plasmid Preparation:Article Title: Design and validation of cell-based potency assays for frataxin supplementation treatments Article Snippet: MEFs were seeded at 5 103–5 104 cells per well in 96-well plates and cultured for 48 h. ATP levels were measured using the Luminescent ATP Detection Assay Kit (Abcam, #ab113849) following the manufacturer’s recommendations. .. Cloning and packaging of pLenti hygro FXN-L A miniFXN construct expressing human FXN under the control of endogenous regulatory elements was cloned into the Article Title: Design and validation of cell-based potency assays for frataxin supplementation treatments. Article Snippet: MEFs were seeded at 5 103–5 104 cells per well in 96-well plates and cultured for 48 h. ATP levels were measured using the Luminescent ATP Detection Assay Kit (Abcam, #ab113849) following the manufacturer’s recommendations. .. Cloning and packaging of pLenti hygro FXN-L A miniFXN construct expressing human FXN under the control of endogenous regulatory elements was cloned into the |